SB257049
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB257049, covering 2024-05-21 to 2024-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age [Phase 2]